Hypertension as a Predictive Factor for Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib after Progression on Cytokines

Publisher： Karger

E-ISSN： 1423-0143|35|1|18-25

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.35, Iss.1, 2011-08, pp. : 18-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Comorbidities for Prediction of Progression-Free Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sorafenib

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 6, 2012-06 ,pp. : 468-476

Karger

Access to resources Recommend Favorite

Serum Vascular Endothelial Growth Factor Is a Candidate Biomarker of Renal Cell Carcinoma in Hemodialysis Patients

By  

Nephron, Vol. 84, Iss. 1, 2000-01 ,pp. : 83-84

Karger

Access to resources Recommend Favorite

Renal Function in Patients Treated with Cinacalcet for Persistent Hyperparathyroidism after Kidney Transplantation

By  

Kidney and Blood Pressure Research, Vol. 34, Iss. 2, 2011-01 ,pp. : 97-103

Karger

Access to resources Recommend Favorite

Low Blood Pressure, Decreased Incidence of Hypertension, and Renal Cardiac, and Autonomic Nervous System Functions in Patients with Sickle Cell Syndromes

By  

Nephron, Vol. 91, Iss. 3, 2002-07 ,pp. : 535-537

Karger

Access to resources Recommend Favorite

Renal Involvement in AA Amyloidosis: Clinical Outcomes and Survival

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 1, 2013-03 ,pp. : 33-42

Karger

Access to resources Recommend Favorite